has knowledgeable contact person
is biomaterial used in
Bio Materials  >  Homo sapiens  >  13 melanoma patients

13 melanoma patients

Homo sapiens

Monocyte-derived and cocktail-matured DC electroporated with a combination of RNAs encoding tumor antigens (MelanA, Mage3, Survivin) and E/L-selectin are currently used in a clinical trial.

Most patients having received the vaccine already demonstrated broad responses to numerous peptides prior vaccination. Significantly enhanced responses to several peptides and occurrence of new responses was seen in 6 patients, 5 of which were vaccinated with E/L-S+ DC. These data provide evidence for a superior immunopotency of E/L-selectin expressing DC.

created over 13 years ago (16 December 2009)    last modified over 12 years ago (28 September 2011)   [ RDF Rdf ]   [ RelFinder Relfinder ]